ClinicalTrials.gg
Drug

Ipratropium clinical trials

Also written Atrovent.

studies test it
40
open now
3
in phase 3
9
first study started
1998

Counted the way a researcher would: Ipratropium with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Ipratropium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ipratropium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1986 · ATROVENT · NDA 019085 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ipratropium bromide
14
Ipratropium
9

Brand

Atrovent
11

In one entry with another drug

Given together, or one or the other

Ipratropium / Levosalbutamol Fixed Dose Combination
2

Studies by the year they started

39 studies that test it; most in 2002 (5)

Studies that test Ipratropium, by start year
YearStudies
19984
19991
20025
20042
20051
20061
20072
20083
20101
20122
20132
20141
20151
20165
20172
20191
20232
20242
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
6
Phase 3
9
Phase 4
12
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 23

Boehringer Ingelheim (9) · GlaxoSmithKline (3) · Neutec Ar-Ge San ve Tic A.Ş (2) · Oregon Health and Science University (1) · State University of New York at Buffalo (1) · Haukeland University Hospital (1) · MetroHealth Medical Center (1) · University of California, San Francisco (1)

Often tested with

Tested in the same studies.

Albuterol (14) · Tiotropium (3) · Levalbuterol (2) · Fenoterol (2) · Propranolol (1) · Ensifentrine (1) · Arformoterol tartrate (1) · Budesonide (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Ipratropium is the comparator. A study of two new drugs counts under both.

  • 1Glycopyrrolate · Post Graduate Institute of Medical Education and Research, Chandigarh

Studies

Open first, then newest update. How each study uses Ipratropium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 40

See all 40 studies that test Ipratropium →

Given beside what is tested · 6 — Ipratropium is usual care or a partner of the new treatment
As the comparator · 11 — what is tested is compared with Ipratropium

Codes

What other systems call Ipratropium · ClinicalTrials.gg INT007861

  • MeSH (NLM) D009241IpratropiumConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) GR88G0I6ULIPRATROPIUMConfirmed FDA, NLM
  • RxNorm 1546373One source FDA
  • NCI Thesaurus C61794IpratropiumOne source FDA

Also registered as ipratropium bromide (UNII J697UZ2A9J · RxNorm 1309404) and ipratropium bromide anhydrous (UNII VJV4X1P2Z1).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.